BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34077388)

  • 1. Texture analysis of orbital magnetic resonance imaging for monitoring and predicting treatment response to glucocorticoids in patients with thyroid-associated ophthalmopathy.
    Wang YY; Wu Q; Chen L; Chen W; Yang T; Xu XQ; Wu FY; Hu H; Chen HH
    Endocr Connect; 2021 Jun; 10(7):676-684. PubMed ID: 34077388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues.
    Hu H; Xu XQ; Chen L; Chen W; Wu Q; Chen HH; Zhu H; Shi HB; Wu FY
    Endocrine; 2020 Nov; 70(2):372-379. PubMed ID: 32504380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.
    Zhai L; Luo B; Wu H; Wang Q; Yuan G; Liu P; Ma Y; Zhao Y; Zhang J
    Eur J Radiol; 2021 Sep; 142():109839. PubMed ID: 34252869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.
    Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S
    Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229
    [No Abstract]   [Full Text] [Related]  

  • 5. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy.
    Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY
    Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2 mapping histogram at extraocular muscles for predicting the response to glucocorticoid therapy in patients with thyroid-associated ophthalmopathy.
    Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Xu XQ; Shi HB; Wu FY
    Clin Radiol; 2021 Feb; 76(2):159.e1-159.e8. PubMed ID: 33010933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
    Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ
    Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter.
    Zhang H; Hu H; Wang Y; Duan X; Chen L; Zhou J; Chen W; Zhang W; Xu X; Chen H
    Eur Thyroid J; 2024 Feb; 13(1):. PubMed ID: 38236726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
    Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
    BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
    Wu T; Tang DR; Wang F; Xia S; Sun FY
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of extraocular muscles for intraocular pressure in thyroid-associated ophthalmopathy patients.
    Tian H; Wang Y; Li J; Li H
    Quant Imaging Med Surg; 2023 Sep; 13(9):5727-5736. PubMed ID: 37711835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.
    Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K
    Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy.
    Zhai L; Wang Q; Liu P; Luo B; Yuan G; Zhang J
    Korean J Radiol; 2022 Jun; 23(6):664-673. PubMed ID: 35555881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image quality and evaluation ability of magnetic resonance imaging techniques for thyroid-associated ophthalmopathy: Dixon fat-suppression technique vs. spectral attenuated inversion recovery.
    Huang K; Lin X; Luo Y; Hu Q; Guo B; Ouyang F; Ouyang Y; Song C; Chen H
    Front Med (Lausanne); 2023; 10():1154828. PubMed ID: 37502355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Peripheral Regulatory T Lymphocytes in Patients with Thyroid Associated Ophthalmopathy During Systemic Glucocorticoid Treatment: A Prospective Observational Study.
    Xu QQ; Zhang XL; Luo B; Li T; Yuan G; Shao SY
    Curr Med Sci; 2023 Feb; 43(1):130-138. PubMed ID: 36459302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
    Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY
    Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
    Kvetny J; Puhakka KB; Røhl L
    Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
    Liu P; Luo B; Chen L; Wang QX; Yuan G; Jiang GH; Zhang J
    Front Endocrinol (Lausanne); 2021; 12():614536. PubMed ID: 33716970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy.
    Zhang J; Liu X; Zhang H; He X; Liu Y; Zhou J; Guo D
    Acad Radiol; 2019 Sep; 26(9):1164-1173. PubMed ID: 30425000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of
    Tang MT; Zeng XY; Li Y; Sun HT; Liu SY; Yuan X; Lu W
    Zhonghua Yan Ke Za Zhi; 2021 Nov; 57(11):830-836. PubMed ID: 34743468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.